Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
Migden, Michael R, Dr, Guminski, Alexander, PhD, Gutzmer, Ralf, Prof, Dirix, Luc, MD, Lewis, Karl D, MD, Combemale, Patrick, MD, Herd, Robert M, MD, Kudchadkar, Ragini, MD, Trefzer, Uwe, Prof, Gogov, Sven, MD, Pallaud, Celine, PhD, Yi, Tingting, PhD, Mone, Manisha, PhD, Kaatz, Martin, MD, Loquai, Carmen, MD, Stratigos, Alexander J, Prof, Schulze, Hans-Joachim, MD, Plummer, Ruth, Prof, Chang, Anne Lynn S, MD, Cornélis, Frank, MD, Lear, John T, MD, Sellami, Dalila, MD, Dummer, Reinhard, Prof
Published in The lancet oncology (01.06.2015)
Published in The lancet oncology (01.06.2015)
Get full text
Journal Article
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma
Dummer, Reinhard, MD, Guminski, Alexander, MD, PhD, Gutzmer, Ralf, MD, Dirix, Luc, MD, Lewis, Karl D., MD, Combemale, Patrick, MD, Herd, Robert M., MD, Kaatz, Martin, MD, Loquai, Carmen, MD, Stratigos, Alexander J., MD, Schulze, Hans-Joachim, MD, Plummer, Ruth, MD, Gogov, Sven, MD, Pallaud, Celine, PhD, Yi, Tingting, PhD, Mone, Manisha, PhD, Chang, Anne Lynn S., MD, Cornélis, Frank, MD, Kudchadkar, Ragini, MD, Trefzer, Uwe, MD, Lear, John T., MD, Sellami, Dalila, MD, Migden, Michael R., MD
Published in Journal of the American Academy of Dermatology (01.07.2016)
Published in Journal of the American Academy of Dermatology (01.07.2016)
Get full text
Journal Article
Phase III Trial of Vandetanib Compared With Erlotinib in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
NATALE, Ronald B, THONGPRASERT, Sumitra, BARLESI, Fabrice, LANGMUIR, Peter, GOGOV, Sven, ROWBOTTOM, Jacqui A, GOSS, Glenwood D, GRECO, F. Anthony, THOMAS, Michael, TSAI, Chun-Ming, SUNPAWERAVONG, Patrapim, FERRY, David, MULATERO, Clive, WHORF, Robert, THOMPSON, Joyce
Published in Journal of clinical oncology (10.03.2011)
Published in Journal of clinical oncology (10.03.2011)
Get full text
Journal Article
First-in-human phase 1 study of the arginase inhibitor INCB001158 alone or combined with pembrolizumab in patients with advanced or metastatic solid tumours
Naing, Aung, Papadopoulos, Kyriakos P, Pishvaian, Michael J, Rahma, Osama, Hanna, Glenn J, Garralda, Elena, Saavedra, Omar, Gogov, Sven, Kallender, Howard, Cheng, LuLu, Smith, Michael, Chen, Xuejun, Kuriakose, Emil, Bauer, Todd
Published in BMJ Oncology (01.07.2024)
Published in BMJ Oncology (01.07.2024)
Get full text
Journal Article
1526 Nous-209 genetic vaccine encoding shared cancer neoantigens is safe and elicits robust immune response in healthy Lynch syndrome carriers: interim results from Phase 1 cancer interception trial
D’Alise, Morena, Willis, Jason, Leoni, Guido, Cruz-Correa, Marcia, Hall, Michael J, Idos, Gregory E, Garzia, Irene, Antonucci, Laura, Cotugno, Gabriella, Siani, Loredana, Gogov, Sven, Liu, Diane, Lee, Jack, Vornik, Lana A, Uribe, Laura Reyes, Garcia-Gonzalez, Araceli, Richmond, Ellen, Umar, Asad, Brown, Powel H, Rodriguez, Luz Maria, Scarselli, Elisa, Vilar, Eduardo
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Low-Intensity Laser Therapy for Painful Symptoms of Diabetic Sensorimotor Polyneuropathy
Zinman, Lorne H., Ngo, Mylan, Ng, Eduardo T., Nwe, Khin T., Gogov, Sven, Bril, Vera
Published in Diabetes care (01.04.2004)
Published in Diabetes care (01.04.2004)
Get full text
Journal Article
Results of phase I-II bridging study for Nous-209, a neoantigen cancer immunotherapy, in combination with pembrolizumab as first line treatment in patients with advanced dMMR/MSI-h colorectal cancer
Overman, Michael J., Maurel, Joan, Oberstein, Paul Eliezer, Roselló-Keränen, Susana, Le, Dung T., Pedersen, Katrina Sophia, Mukherjee, Sarbajit, D'Alise, Anna Morena, Leoni, Guido, Siani, Loredana, Scarselli, Elisa, Faivre, Théa, Delaite, Patricia, Gogov, Sven, Fakih, Marwan
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses
D'Alise, Anna Morena, Leoni, Guido, Cotugno, Gabriella, Siani, Loredana, Vitale, Rosa, Ruzza, Valentino, Garzia, Irene, Antonucci, Laura, Micarelli, Elisa, Venafra, Veronica, Gogov, Sven, Capone, Alessia, Runswick, Sarah, Martin-Liberal, Juan, Calvo, Emiliano, Moreno, Victor, Symeonides, Stefan N, Scarselli, Elisa, Bechter, Oliver
Published in Clinical cancer research (03.06.2024)
Published in Clinical cancer research (03.06.2024)
Get full text
Journal Article
Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors
Macaulay, Valentine M, Middleton, Mark R, Eckhardt, S Gail, Rudin, Charles M, Juergens, Rosalyn A, Gedrich, Richard, Gogov, Sven, McCarthy, Sean, Poondru, Srinivasu, Stephens, Andrew W, Gadgeel, Shirish M
Published in Clinical cancer research (15.06.2016)
Published in Clinical cancer research (15.06.2016)
Get full text
Journal Article
Population pharmacokinetics of sonidegib (LDE225), an oral inhibitor of hedgehog pathway signaling, in healthy subjects and in patients with advanced solid tumors
Goel, Varun, Hurh, Eunju, Stein, Andrew, Nedelman, Jerry, Zhou, Jocelyn, Chiparus, Ovidiu, Huang, Pai-Hsi, Gogov, Sven, Sellami, Dalila
Published in Cancer chemotherapy and pharmacology (01.04.2016)
Published in Cancer chemotherapy and pharmacology (01.04.2016)
Get full text
Journal Article
A phase I/II study of safety and efficacy of the arginase inhibitor INCB001158 plus chemotherapy in patients (Pts) with advanced biliary tract cancers
Javle, Milind M., Bridgewater, John A., Gbolahan, Olumide B., Jungels, Christiane, Cho, May Thet, Papadopoulos, Kyriakos P., Thistlethwaite, Fiona C., Canon, Jean-Luc Re, Cheng, Lulu, Ioannidis, Sonia, Gogov, Sven, Naing, Aung
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study
Guo, Jun, Huang, Yiran, Zhang, Xu, Zhou, Fangjian, Sun, Yinghao, Qin, Shukui, Ye, Zhangqun, Wang, Hui, Jappe, Annette, Straub, Patrick, Pirotta, Nicoletta, Gogov, Sven
Published in BMC cancer (21.03.2013)
Published in BMC cancer (21.03.2013)
Get full text
Journal Article
Abstract LB196: NOUS-PEV, a personalized cancer immunotherapy targeting neoantigens, induces long lasting, tumor infiltrating memory T cells
Bechter, Oliver, D'Alise, Anna Morena, Leoni, Guido, Cotugno, Gabriella, Siani, Loredana, Vitale, Rosa, Ruzza, Valentino, Garzia, Irene, Antonucci, Laura, Micarelli, Elisa, Gogov, Sven, Capone, Alessia, Martin-Liberal, Juan, Calvo, Emiliano, Moreno, Victor, Symeonides, Stefan, Scarselli, Elisa
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
706 NOUS-PEV, a novel personalized viral-based prime/boost cancer immunotherapy targeting patient-specific neoantigens: interim results from the first subjects in the phase 1b study
Bechter, Oliver, Martin-Liberal, Juan, Anna D’Alise, Leoni, Guido, Cotugno, Gabriella, Siani, Loredana, Vitale, Rosa, Ruzza, Valentino, Micarelli, Elisa, Garzia, Irene, Faivre, Thea, Gogov, Sven, Delaite, Patricia, Colloca, Stefano, Ambrosio, Maria, Merone, Rossella, Scarselli, Elisa, Symeonides, Stefan
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article
Composite assessment of treatment response in patients (pts) with locally advanced basal cell carcinoma (laBCC): Sonidegib efficacy using two sets of response criteria
Dummer, Reinhard, Sondak, Vernon K., Grichnik, James M, Schwartz, Lawrence H., Gogov, Sven, Yi, Tingting, Mone, Manisha, Trylesinski, Aldo, Sellami, Dalila B., Migden, Michael Robert
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Randomized, double-blind study of sonidegib (LDE225) in patients (pts) with locally advanced (La) or metastatic (m) basal-cell carcinoma (BCC)
Migden, Michael Robert, Guminski, Alexander David, Gutzmer, Ralf, Dirix, Luc Yves, Lewis, Karl D., Combemale, Patrick, Herd, Robert, Gogov, Sven, Yi, Tingting, Mone, Manisha, Kudchadkar, Ragini Reiney, Trefzer, Uwe, Lear, John, Sellami, Dalila B., Dummer, Reinhard
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Relationship between biomarkers and everolimus efficacy in the phase III RECORD-1 trial of patients with metastatic renal cell carcinoma (mRCC)
Oudard, Stephane, Escudier, Bernard J., Thompson, John A., Grünwald, Viktor, Masini, Cristina, Bracarda, Sergio, Panneerselvam, Ashok, Gogov, Sven, Chen, David, Motzer, Robert John
Published in Journal of clinical oncology (20.02.2013)
Published in Journal of clinical oncology (20.02.2013)
Get full text
Journal Article
Randomized phase II study of first-line everolimus plus bevacizumab (E+B) versus interferon α-2a plus bevacizumab (I+B) in patients (pts) with metastatic renal cell carcinoma (mRCC): Record-2 final overall survival (OS) and safety results
Ravaud, Alain, Barrios, Carlos H., Alekseev, Boris Y., Tay, Miah Hiang, Agarwala, Sanjiv S., Yalcin, Suayib, Lin, Chia-Chi, Shkolnik, Michail, Matveev, Vsevolod, Anak, Ozlem, Gogov, Sven, Pelov, Diana, Louveau, Anne-Laure, Vaury, Alexandra, Melichar, Bohuslav
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC)
Motzer, Robert John, Barrios, Carlos H., Kim, Tae Min, Falcon, Silvia, Cosgriff, Thomas, Harker, W. Graydon, Pittman, Kenneth B., Sabbatini, Roberto, Rha, Sun Young, Flaig, Thomas W., Page, Ray D., Bavbek, Sevil E., Beck, J. Thaddeus, Patel, Poulam M, Schiff, Edward, Vaury, Alexandra, Niolat, Julie, Gogov, Sven, Anak, Ozlem, Knox, Jennifer
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article